亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy and safety of ceftazidime-avibactam compared to other antimicrobials for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis

荟萃分析 粘菌素 肺炎克雷伯菌 头孢他啶/阿维巴坦 医学 抗菌剂 替加环素 科克伦图书馆 内科学 头孢他啶 不利影响 重症监护医学 阿维巴坦 微生物学 生物 铜绿假单胞菌 生物化学 遗传学 大肠杆菌 基因 细菌
作者
Theodoros Karampatakis,Katerina Tsergouli,Kinga Lowrie
出处
期刊:Microbial Pathogenesis [Elsevier]
卷期号:179: 106090-106090 被引量:6
标识
DOI:10.1016/j.micpath.2023.106090
摘要

Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections are a significant public health issue. CRKP infections can increase the mortality of severely ill hospitalised patients and elevate the financial burden of their hospitalisation globally. Colistin and tigecycline are the main antimicrobials which have been widely used for the treatment of CRKP infections. However, novel antimicrobials have been recently launched. Ceftazidime-avibactam (CAZ-AVI) seems one of the most efficient ones.The aim of the current systematic literature review and meta-analysis is to assess the efficacy and safety of CAZ-AVI compared to other antimicrobials in adult patients (aged >18) with CRKP infection.All data were retrieved using PubMed/Medline, the Web of Science and Cochrane library. The main outcome was the effective treatment of CRKP infection or the microbiological eradication of CRKP in the culture of biological samples. Secondary outcomes included the impact on 28- or 30-day mortality and adverse effects, if available. Pooled analysis was conducted using Review Manager v. 5.4.1 software (RevMan). The level of statistical significance was set at p < 0.05.CAZ-AVI was proved more effective than other antimicrobials against CRKP infections and CRKP bloodstream infections (p < 0.00001 and p < 0.0001, respectively). Patients in the CAZ-AVI arm displayed statistically lower 28- and 30-day mortality rates (p = 0.002 and p < 0.00001, respectively). Concerning the microbiological eradication, no meta-analysis was feasible due to high heterogeneity.The promotion of CAZ-AVI for treating CRKP infections over other antimicrobials seems favourable. However, there is a long way ahead to reveal additional scientific findings to further strengthen this statement.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qianchang完成签到,获得积分10
52秒前
腼腆的康完成签到 ,获得积分10
52秒前
jerry完成签到 ,获得积分20
1分钟前
丘比特应助科研通管家采纳,获得10
1分钟前
wxl完成签到,获得积分10
1分钟前
PL完成签到,获得积分10
2分钟前
adcc102完成签到 ,获得积分10
2分钟前
2分钟前
欣嫩谷发布了新的文献求助10
2分钟前
cydanyanpi完成签到,获得积分10
2分钟前
3分钟前
3分钟前
松林揽月发布了新的文献求助10
3分钟前
传奇3应助科研通管家采纳,获得10
3分钟前
3分钟前
3分钟前
松林揽月发布了新的文献求助10
3分钟前
4分钟前
松林揽月发布了新的文献求助10
4分钟前
松林揽月发布了新的文献求助10
4分钟前
研友_VZG7GZ应助欢欢采纳,获得10
5分钟前
CipherSage应助科研通管家采纳,获得10
5分钟前
欢欢完成签到,获得积分10
5分钟前
5分钟前
5分钟前
5分钟前
Tim完成签到 ,获得积分10
5分钟前
5分钟前
彭于晏应助11111111采纳,获得10
5分钟前
兰子君11完成签到 ,获得积分10
5分钟前
6分钟前
11111111发布了新的文献求助10
6分钟前
11111111完成签到,获得积分10
6分钟前
领导范儿应助科研通管家采纳,获得10
7分钟前
7分钟前
7分钟前
领导范儿应助雨朵采纳,获得10
8分钟前
爱学习的YY完成签到 ,获得积分10
8分钟前
坚强桐发布了新的文献求助10
8分钟前
ll关闭了ll文献求助
9分钟前
高分求助中
歯科矯正学 第7版(或第5版) 1004
Semiconductor Process Reliability in Practice 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 600
GROUP-THEORY AND POLARIZATION ALGEBRA 500
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
Days of Transition. The Parsi Death Rituals(2011) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3234564
求助须知:如何正确求助?哪些是违规求助? 2880908
关于积分的说明 8217339
捐赠科研通 2548510
什么是DOI,文献DOI怎么找? 1377809
科研通“疑难数据库(出版商)”最低求助积分说明 648006
邀请新用户注册赠送积分活动 623361